Faculty of 1000 Biology | Faculty member: Raymond Harris

4-Jul-2008

About F1000

What is F1000 Biology?
Key features
How it's organized
FAQs
Faculties and sections
Scope of sections
List of Faculty Members
The evaluation system
Citing F1000
Take a tour of the site
Accessing fulltexts
PubMed linkout
How to subscribe
Academic subscriptions
Corporate subscriptions
Try F1000 for free
Who we are
Media information
Librarian resources
Press releases
In the press
Developing countries
F1000 Medicine
Terms and conditions
Privacy policy
Contact us

	Raymond Harris Division of Nephrology, Vanderbilt University School of Medicine, Nashville, United States of America
	Faculty Member: PHYSIOLOGY > Renal, fluid & electrolyte physiology [ since 21 November 2005 ]

[ Evaluations ]

email [Help]

Evaluations

The Collecting Duct Is the Major Source of Prorenin in Diabetes.
Kang JJ, Toma I, …, Vargas SL, Peti-Peterdi J
Hypertension 2008 Apr 14 [abstract on PubMed] [related articles] [full text]

Selected by | Raymond Harris
Evaluated 22 Apr 2008

alpha-Klotho as a regulator of calcium homeostasis.
Imura A, Tsuji Y, …, Fujimori T, Nabeshima Y
Science 2007 Jun 15 316(5831):1615-8 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Raymond Harris
Evaluated 16 Aug 2007

Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.
Crowley SD, Gurley SB, …, Le TH, Coffman TM
Proc Natl Acad Sci U S A 2006 Nov 21 103(47):17985-90 [abstract on PubMed] [related articles] [FREE full text]

Selected by | Matthew Breyer / Soeren Sheikh / Raymond Harris / Anna Dominiczak / Tom Lohmeier / David J Webb / Robert Carey
Evaluated 30 Nov 2006

Mitochondria as signaling organelles in the vascular endothelium.
Quintero M, Colombo SL, Godfrey A, Moncada S
Proc Natl Acad Sci U S A 2006 Apr 4 103(14):5379-84 [abstract on PubMed] [related articles] [FREE full text]

Selected by | Raymond Harris
Evaluated 17 May 2006

Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach.
Lautrette A, Li S, …, Friedlander G, Terzi F
Nat Med 2005 Aug 11(8):867-74 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Raymond Harris
Evaluated 18 Apr 2006

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.
Shillingford JM, Murcia NS, …, Germino GG, Weimbs T
Proc Natl Acad Sci U S A 2006 Apr 4 103(14):5466-71 [abstract on PubMed] [related articles] [FREE full text]

Selected by | Raymond Harris / David Cook
Evaluated 18 Apr 2006

^Top Back to Faculty Members